Benralizumab treatment for severe nasal polyps

We are seeking adults with severe nasal polyps to undergo a new medication treatment study.

  • The research study involves six visits that will take about two hours each.

  • You must be between the ages of 18 and 75 to participate. Being pregnant or recent use of antibody therapy will exclude you from participating.

  • If you are eligible and choose to participate, compensation is $400.

For more information about this research study, please contact Dea Cunningham at or by phone at 410-550-8017.

Principal investigator: Jody Tversky, MD
Study number: IRB00112910